| Katherine Paulick, PSYD | |
|
2250 S Woodworth Loop, Suite 202, Palmer, AK 99645-7457 | |
| (907) 761-5800 | |
| (907) 761-5801 |
| Full Name | Katherine Paulick |
|---|---|
| Gender | Female |
| Speciality | Clinical Psychologist |
| Experience | 8 Years |
| Location | 2250 S Woodworth Loop, Palmer, Alaska |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1679925325 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 103TC0700X | Psychologist - Clinical | 112420 (Alaska) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Providence Health And Services Washington | 8628965910 | 41 |
News Archive
Takeda Pharmaceutical Company Limited (Takeda) announced today that Takeda Global Research & Development Center, Inc., U.S., submitted a New Drug Application (NDA) to the United States Food and Drug Administration (FDA) for azilsartan medoxomil (development code: TAK-491), an angiotensin II receptor blocker (ARB) under investigation for the treatment of hypertension. Discovered by Takeda, azilsartan medoxomil is designed to lower blood pressure by blocking the action of a vasopressor hormone, angiotensin II.
Local charities are being invited to apply for a $100,000 grant through Humana Communities Benefit, an award program sponsored by health benefits company Humana Inc.
Stanford physicists and eye doctors have teamed up to design a "bionic eye," of sorts. On Feb. 22 in the Journal of Neural Engineering, Daniel Palanker, Alexander Vankov and Phil Huie from the Department of Ophthalmology and the Hansen Experimental Physics Laboratory and Stephen Baccus from the Department of Neurobiology published a design of an optoelectronic retinal prosthesis system that can stimulate the retina with resolution corresponding to a visual acuity of 20/80
Having the guidance of a caring adult mentor may help overcome symptoms of depression among young people, according to a five-year study of 1,300 youth in Washington State.
In late December, nearly two years after the epidemic began, the World Health Organization has declared the African country of Guinea to be free of Ebola virus infections. But, the race to find a cure and therapies to combat the disease are forging ahead as officials warn that inattention could lead to another epidemic.
› Verified 8 days ago
| Entity Name | Providence Health & Services Washington |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1538254347 PECOS PAC ID: 8628965910 Enrollment ID: O20040302000372 |
News Archive
Takeda Pharmaceutical Company Limited (Takeda) announced today that Takeda Global Research & Development Center, Inc., U.S., submitted a New Drug Application (NDA) to the United States Food and Drug Administration (FDA) for azilsartan medoxomil (development code: TAK-491), an angiotensin II receptor blocker (ARB) under investigation for the treatment of hypertension. Discovered by Takeda, azilsartan medoxomil is designed to lower blood pressure by blocking the action of a vasopressor hormone, angiotensin II.
Local charities are being invited to apply for a $100,000 grant through Humana Communities Benefit, an award program sponsored by health benefits company Humana Inc.
Stanford physicists and eye doctors have teamed up to design a "bionic eye," of sorts. On Feb. 22 in the Journal of Neural Engineering, Daniel Palanker, Alexander Vankov and Phil Huie from the Department of Ophthalmology and the Hansen Experimental Physics Laboratory and Stephen Baccus from the Department of Neurobiology published a design of an optoelectronic retinal prosthesis system that can stimulate the retina with resolution corresponding to a visual acuity of 20/80
Having the guidance of a caring adult mentor may help overcome symptoms of depression among young people, according to a five-year study of 1,300 youth in Washington State.
In late December, nearly two years after the epidemic began, the World Health Organization has declared the African country of Guinea to be free of Ebola virus infections. But, the race to find a cure and therapies to combat the disease are forging ahead as officials warn that inattention could lead to another epidemic.
› Verified 8 days ago
| Entity Name | Providence Health & Services- Washington |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1093956278 PECOS PAC ID: 1557408176 Enrollment ID: O20091029000679 |
News Archive
Takeda Pharmaceutical Company Limited (Takeda) announced today that Takeda Global Research & Development Center, Inc., U.S., submitted a New Drug Application (NDA) to the United States Food and Drug Administration (FDA) for azilsartan medoxomil (development code: TAK-491), an angiotensin II receptor blocker (ARB) under investigation for the treatment of hypertension. Discovered by Takeda, azilsartan medoxomil is designed to lower blood pressure by blocking the action of a vasopressor hormone, angiotensin II.
Local charities are being invited to apply for a $100,000 grant through Humana Communities Benefit, an award program sponsored by health benefits company Humana Inc.
Stanford physicists and eye doctors have teamed up to design a "bionic eye," of sorts. On Feb. 22 in the Journal of Neural Engineering, Daniel Palanker, Alexander Vankov and Phil Huie from the Department of Ophthalmology and the Hansen Experimental Physics Laboratory and Stephen Baccus from the Department of Neurobiology published a design of an optoelectronic retinal prosthesis system that can stimulate the retina with resolution corresponding to a visual acuity of 20/80
Having the guidance of a caring adult mentor may help overcome symptoms of depression among young people, according to a five-year study of 1,300 youth in Washington State.
In late December, nearly two years after the epidemic began, the World Health Organization has declared the African country of Guinea to be free of Ebola virus infections. But, the race to find a cure and therapies to combat the disease are forging ahead as officials warn that inattention could lead to another epidemic.
› Verified 8 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Katherine Paulick, PSYD Po Box 4105, Portland, OR 97208-4105 Ph: (866) 907-1068 | Katherine Paulick, PSYD 2250 S Woodworth Loop, Suite 202, Palmer, AK 99645-7457 Ph: (907) 761-5800 |
News Archive
Takeda Pharmaceutical Company Limited (Takeda) announced today that Takeda Global Research & Development Center, Inc., U.S., submitted a New Drug Application (NDA) to the United States Food and Drug Administration (FDA) for azilsartan medoxomil (development code: TAK-491), an angiotensin II receptor blocker (ARB) under investigation for the treatment of hypertension. Discovered by Takeda, azilsartan medoxomil is designed to lower blood pressure by blocking the action of a vasopressor hormone, angiotensin II.
Local charities are being invited to apply for a $100,000 grant through Humana Communities Benefit, an award program sponsored by health benefits company Humana Inc.
Stanford physicists and eye doctors have teamed up to design a "bionic eye," of sorts. On Feb. 22 in the Journal of Neural Engineering, Daniel Palanker, Alexander Vankov and Phil Huie from the Department of Ophthalmology and the Hansen Experimental Physics Laboratory and Stephen Baccus from the Department of Neurobiology published a design of an optoelectronic retinal prosthesis system that can stimulate the retina with resolution corresponding to a visual acuity of 20/80
Having the guidance of a caring adult mentor may help overcome symptoms of depression among young people, according to a five-year study of 1,300 youth in Washington State.
In late December, nearly two years after the epidemic began, the World Health Organization has declared the African country of Guinea to be free of Ebola virus infections. But, the race to find a cure and therapies to combat the disease are forging ahead as officials warn that inattention could lead to another epidemic.
› Verified 8 days ago
Dr. Angie Reather Cronin, PSY.D. Psychologist Medicare: Accepting Medicare Assignments Practice Location: 2250 S Woodworth Loop Ste 202, Palmer, AK 99645 Phone: 907-761-5800 | |
Dr. Grace M Long, PH.D. Psychologist Medicare: Not Enrolled in Medicare Practice Location: 642 S Alaska St Ste 218, Palmer, AK 99645 Phone: 907-746-1212 Fax: 907-746-7307 | |
Ms. Judy Margarete Cordell, L.P.A. Psychologist Medicare: Not Enrolled in Medicare Practice Location: 1825 S Chugach St, Palmer, AK 99645 Phone: 907-376-4000 | |
Dustin M Logan, PHD Psychologist Medicare: Accepting Medicare Assignments Practice Location: 8201 N Michaelson St, Palmer, AK 99645 Phone: 907-745-5066 Fax: 907-746-2851 | |
Dr. Melinda H. Glass, PH.D. Psychologist Medicare: Not Enrolled in Medicare Practice Location: 642 S Alaska St, Suite 219, Palmer, AK 99645 Phone: 907-746-7306 |